Leaflet: information for the user
Medikinet 10 mg modified-release hard capsules
metilphenidate hydrochloride
This medicine is subject to additional monitoring, which will speed up the detection of any new information about its safety. You can contribute by reporting any adverse effects you may experience. The final part of section 4 includes information on how to report these adverse effects.
Read this leaflet carefully before you or your child start taking this medicine, because it contains important information for you.
|
What it is used for
Medikinet is used to treat "attention deficit hyperactivity disorder" (ADHD).
Medikinet is not indicated for the treatment of ADHD in children under 6 years old.
How it works
Medikinet improves the activity of certain parts of the brain that have low activity. The medication may help improve attention and concentration levels and reduce impulsive behavior.
The medication is administered as part of an integrated treatment program, which usually includes psychological, educational, and social therapy.
The treatment with Medikinet should only be initiated by a doctor, a specialist in ADHD treatment, such as a pediatrician, a child and adolescent psychiatrist, or a psychiatrist, and should be used under their supervision. This doctor must perform a thorough medical examination. If you, as an adult, have not received this type of treatment before, the doctor will perform tests to confirm that you have had ADHD since childhood. Although ADHD has no cure, it can be controlled using integrated treatment programs.
About ADHD
Children and adolescents with ADHD have:
It is not their fault that they cannot do these things.
Patients may present different degrees of ADHD with symptoms such as:
•lack of concentration
•restlessness
•hyperactivity
•impulsivity
•emotional instability
•disorganized thinking
Some external signs are:
•difficulty concentrating
•forgetfulness
•excessive use of words (verborrea)
•difficulty planning and executing tasks until completion
•impulsive actions
•impatience
ADHD does not affect the child's or adolescent's intelligence.
Do not take Medikinet if you or your child
-a "psychopathic" disorder or a "borderline personality disorder"
-abnormal thoughts or visions or a disease called "schizophrenia"
-signs of a severe mood disorder, such as:
-suicidal thoughts
-severe depression, feeling very sad, despised and desperate
-mania, feeling exceptionally excited, more active than normal and uninhibited.
Do not take methylphenidate if you or your child present any of the above. If you are unsure, inform your doctor or pharmacist before you or your child take methylphenidate. This is because methylphenidate may worsen these problems.
Warnings and precautions
Consult your doctor before starting to take Medikinet if you or your child
-bipolar disorder (alternating between mania and depression)
-aggressive or hostile behavior, or if aggression worsens
-seeing, hearing or feeling things that are not there (hallucinations)
-believing things that are not real (delusions)
-feeling suspiciously paranoid
-feeling agitated, anxious or tense
-feeling depressed or guilty.
Inform your doctor or pharmacist if you or your child present any of the above before starting treatment. Methylphenidate may worsen these problems. Your doctor will want to monitor how the medication affects you or your child.
During treatment, children and adolescents may unexpectedly experience prolonged erections. Erections can be painful and occur at any time. It is essential to contact your doctor immediately if the erection lasts more than 2 hours, especially if it is painful.
Checks your doctor will make before you or your child start taking methylphenidate
To decide if methylphenidate is the right medication for you or your child, your doctor will check with you the following aspects:
Your doctor will explain specifically if you or your child are at risk of developing mood swings (alternating between mania and depression, known as bipolar disorder). Your doctor will also check your or your child's mental health history and check if any family members have a history of suicide, bipolar disorder or depression.
It is essential to provide all the information you can. This will help your doctor decide if methylphenidate is the right medication for you or your child. Your doctor may decide that you or your child need other medical tests before starting this medication.
Drug analysis
This medication may give positive results in drug tests.
Competitors should be aware that this medication may produce a positive result in doping control tests.
Taking Medikinet with other medicines
Inform your doctor or pharmacist if you or your child aretaking, havetakenrecentlyor may need to take any other medication.
Do not take metilfenidato if you or your child:
If you or your child are taking other medications, methylphenidate may affect the mechanism of action of these medications or cause adverse effects. Inform your doctor if you or your child are taking medications to treat:
Medikinet should not be taken with H2 blockers, proton pump inhibitors or antacids (medications to reduce stomach acid secretion or to treat excessive stomach acid), as they may cause a faster release of the total amount of active ingredient.
If you have any doubts about whether any of the medications you or your child are taking are included in the above list, consult your doctor or pharmacist for advice before taking methylphenidate.
Before surgery
Inform your doctor if you or your child are undergoing surgery. Do not take methylphenidate on the day of surgery with certain types of anesthetics, as it may cause a sudden increase in blood pressure during the procedure.
Taking metilfenidato with alcohol
Do not drink alcohol while taking this medication. Alcohol may worsen the adverse effects of this medication. Remember that some foods and medications contain alcohol.
Pregnancy and breastfeeding
The available data do not suggest an increased risk of total congenital anomalies, although a small increased risk of cardiac malformations cannot be ruled out during the first three months of pregnancy. Your doctor will provide you with more information about this risk.
Consult your doctor or pharmacist before using methylphenidate if you or your daughter:
Driving and operating machinery
You or your child may experience dizziness, drowsiness, difficulty focusing or blurred vision, hallucinations or other central nervous system effects when taking methylphenidate. If this occurs, it may be hazardous to perform certain activities, such as driving, operating machinery, riding a bike or horse, or climbing trees.
Medikinet contains saccharose
If your doctor has indicated that you or your child have an intolerance to certain sugars, consult with them before taking this medication.
Medikinet contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per capsule; it is essentially "sodium-free".
Dose
Use in children
The maximum daily dose is 60 mg.
Use in adults
For adults who have taken Medikinet before
For adults who have not taken Medikinet before
The recommended initial dose is 10 mg per day.
Things your doctor will do during your treatment or your child's treatment
Your doctor will perform some tests
How to take
This medication is for oral administration.
Medikinet should be taken by children in the morningwith or afterbreakfast.
Medikinet should be taken by adultswith or afterbreakfast and lunch.
Medikinet is a form of methylphenidate with a "controlled release" action, which releases the medication gradually over a prolonged period. It is very important to take the capsule with or after meals to prolong its action.
The capsules can be swallowed whole with a little water or can be opened and the contents sprinkled over a small amount (a tablespoon) of apple sauce or yogurt, and taken immediately. Do not store it for future use.
The capsules and their contents should not be crushed or chewed.
If you or your child do not feel better after 1 month of treatment
If you or your child do not feel better after 1 month of treatment, inform your doctor. Your doctor may decide if you or your child need a different treatment.
Long-term treatment
Medikinet does not need to be taken indefinitely. If you or your child take Medikinet for more than a year, your doctor should interrupt treatment at least once a year for a short period of time. In the case of children, the interruption can be done during school vacations. This allows you to demonstrate if you still need the medication.
Improper use ofMedikinet
If Medikinet is not used properly, it may cause abnormal behavior. This can also mean that you or your child start to depend on the medication. Inform your doctor if you or your child have abused or have been dependent on alcohol, prescription medications, or illegal drugs.
This medication has been prescribed only to you and should not be given to others, even if they have the same symptoms as you.
If you or your child take moreMedikinetthan you should
In case of overdose or accidental ingestion, call your doctor, the nearest hospital emergency service, or the Toxicology Information Service, phone: 91 562 04 20 indicating the medication and the amount ingested. You may need medical treatment.
The signs of overdose may include: vomiting, agitation, tremors, uncontrolled movements, muscle contractions, seizures (sometimes followed by coma), feeling extremely happy, confusion, seeing, feeling, or hearing things that are not real (hallucinations), sweating, flushing, headache, high fever, changes in heart rate (slow, fast, or irregular), high blood pressure, dilated pupils, and dryness of the nose and mouth, muscle spasms, fever, and darkening of urine to a reddish-brown color that may be possible signs of abnormal muscle breakdown (rhabdomyolysis).
If you or your child forget to takeMedikinet
Do not take a double dose to make up for the missed doses. If you or your child forget a dose, wait to take the next dose at the scheduled time.
If you or your child stop takingMedikinet
If you or your child stop taking this medication suddenly, you may experience a return of ADHD symptoms or unwanted effects, such as depression. Your doctor may want to gradually reduce the amount of medication you take each day before stopping it completely. Consult your doctor before stopping treatment with Medikinet.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Some side effects can be serious. If you or your child experience any of the following side effects, seek medical attention immediately:
Frequent: can affect up to 1 in 10 people
Infrequent: can affect up to 1 in 100 people
Rare: can affect up to 1 in 1,000 people
Very rare: can affect up to 1 in 10,000 people
Unknown: the frequency cannot be estimated with available data
If you or your child experience any of the side effects listed above, seek medical attention immediately.
The following side effects are listed below, and if they become serious, please seek medical attention or contact your pharmacist immediately:
Very frequent: can affect more than 1 in 10 people
Frequent: can affect up to 1 in 10 people
Aggression, agitation, restlessness, emotional instability, anxiety, depression, stress, irritable and abnormal behavior, difficulty sleeping, fatigue
Infrequent: can affect up to 1 in 100 people
Rare: can affect up to 1 in 1,000 people
Very rare: can affect up to 1 in 10,000 people
Unknown: the frequency cannot be estimated with available data
Effects on growth
Methylphenidate may reduce growth in some children when taken for more than a year. This affects less than 1 in 10 children.
Communication of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister pack and on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30°C.
Store in the original packaging to protect the medication from moisture.
Medications should not be disposed of through drains or in the trash.Deposit the containers and medications you no longer need at the SIGRE point of your pharmacy.Ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.
The active ingredient is: methylphenidate hydrochloride.
Each modified-release hard capsule contains 10 mg of methylphenidate hydrochloride equivalent to 8.65 mg of methylphenidate.
The other components are:
Hard capsule content:
Sugar spheres (containing sucrose and cornstarch), methacrylic acid-ethyl acrylate copolymer (1:1), talc, triethyl citrate, polyvinyl alcohol, macrogol 3350, polysorbate 80, sodium hydroxide, sodium lauryl sulfate, simethicone, anhydrous colloidal silica, methylcellulose, sorbic acid, indigo carmine, aluminium lake (E-132).
Hard capsule coating:
Gelatin, erythrosine (E-127), titanium dioxide (E-171), sodium lauryl sulfate, purified water, azorubine (E-131)
Appearance of theproduct and contents of the package
Body of the hard capsule opaque white/cap of the hard capsule opaque purple (15.9 mm) containing white and blue pellets.
Package sizes: Boxes of 20, 24, 27, 28, 30, 36, 45, 48, 50, 54, 60, 63, 90, 96 or 99 modified-release hard capsules, packaged in PVC/PVdC aluminium blisters.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
MEDICE Arzneimittel Pütter GmbH & Co. KG
Kuhloweg 37
58638 Iserlohn
Germany
Manufacturer:
MEDICE Arzneimittel Pütter GmbH & Co. KG
Kuhloweg 37
58638 Iserlohn
Germany
Local representative:
Laboratorios Farmacéuticos ROVI, S.A.
Julián Camarillo, 35
28037 Madrid
This medicinal product is authorized in the member states of the European Economic Area with the following names:
Germany:Medikinet retard 10 mg Hartkapseln mit veränderter Wirkstofffreisetzung
Austria:Medikinet retard 10 mg Hartkapseln mit veränderter Wirkstofffreisetzung
Denmark:Medikinet CR 10 mg
Spain:Medikinet 10 mg cápsulas duras de liberación modificada
Finland:Medikinet CR 10 mg
Iceland:Medikinet CR 10 mghart hylki með breyttan losunarhraða
Luxembourg:Medikinet retard 10 mg Hartkapseln mit veränderter Wirkstofffreisetzung
Netherlands:Medikinet CR 10 mg capsule met gereguleerde afgifte, hard
Norway:Medikinet 10 mg Kapsel med modifisert frisetting, hard
Poland:Medikinet CR 10 mg
Sweden:Medikinet 10 mg Kapsel med modifierad frisättning,hård
United Kingdom:Medikinet XL 10 mg modified-release capsules hard
Date of the last review of this leaflet:June 2022
The detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.